MOUNTAIN VIEW, Calif., March 8 /PRNewswire/ -- Aviron (Nasdaq: AVIR)
announced today that it has filed a Registration Statement with the Securities
and Exchange Commission with respect to the offering of 3,000,000 shares of
its common stock. The underwriters have the option to purchase up to an
additional 450,000 shares (100,000 from a selling stockholder and 350,000 from
the company) to cover over-allotments. The underwriters for the offering will
be Morgan Stanley Dean Witter, Bear, Stearns & Co. Inc. and U.S. Bancorp Piper
Jaffray.
Concurrent with and contingent upon the proposed public offering, the
company expects to sell approximately $14.7 million of its common stock to
American Home Products Corporation in a private placement at a price per share
equal to the net proceeds per share to the company in the public offering.
A Registration Statement relating to the securities to be sold in the
public offering has been filed with the Securities and Exchange Commission,
but is not yet effective. These securities may not be sold nor may offers to
buy be accepted prior to the time the Registration Statement becomes
effective. This press release shall not constitute an offer to sell or the
solicitation of an offer to buy. There shall not be any sale of these
securities in any state in which such offer, solicitation, or sale would be
unlawful prior to registration or qualification under the securities laws of
any such state.
Aviron is a biopharmaceutical company based in Mountain View, California,
focused on the prevention of disease through innovative vaccine technology.
Copies of the preliminary prospectus relating to the public offering are
not yet available. When they become available you may obtain a copy by
contacting Morgan Stanley Dean Witter, 1585 Broadway, New York, NY 10036,
212-761-4000; Bear, Stearns & Co. Inc., 245 Park Avenue, New York, NY 10167,
Attention: Prospectus Department, 212-272-2000; or U.S. Bancorp Piper
Jaffray, 222 South Ninth Street, Minneapolis, MN 55402, 800-333-6000.
SOURCE Aviron
 back to top
Related links:
http://www.aviron.com
Company News On-Call:
http://www.prnewswire.com/comp/114000.html or fax,
800-758-5804, ext. 114000
CONTACT:
John Bluth of Aviron, 650-919-6500
|
